Molecular Partners AG (SWX:MOLN)
3.175
+0.125 (4.10%)
Last updated: Apr 2, 2026, 3:18 PM CET
Molecular Partners AG Employees
Molecular Partners AG had 134 employees as of December 31, 2025. The number of employees decreased by 25 or -15.46% compared to the previous year.
Employees
134
Change
-25
Growth
-15.46%
Revenue / Employee
n/a
Profits / Employee
-460.08K CHF
Market Cap
114.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 134 | -25 | -15.46% |
| Jun 30, 2025 | 153 | -9 | -5.50% |
| Dec 31, 2024 | 159 | -9 | -5.37% |
| Jun 30, 2024 | 162 | -7 | -3.92% |
| Dec 31, 2023 | 168 | -8 | -4.45% |
| Jun 30, 2023 | 169 | 5 | 2.74% |
| Dec 31, 2022 | 175 | 12 | 7.41% |
| Jun 30, 2022 | 164 | 12 | 7.89% |
| Dec 31, 2021 | 163 | 18 | 12.24% |
| Mar 31, 2021 | 152 | 17 | 12.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Basilea Pharmaceutica AG | 189 |
| Santhera Pharmaceuticals Holding AG | 79 |
| BioVersys AG | 29 |
| Newron Pharmaceuticals | 22 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Molecular Partners AG News
- 10 days ago - Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors - GlobeNewsWire
- 14 days ago - Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes - GlobeNewsWire
- 16 days ago - Molecular Partners to Hold Three Poster Presentations at AACR 2026 - GlobeNewsWire
- 21 days ago - Molecular Partners Reports Highlights and Financial Results for Full Year 2025 - GlobeNewsWire
- 5 weeks ago - Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results - GlobeNewsWire
- 2 months ago - Molecular Partners AG (MOLN) Discusses Clinical Imaging and Dosimetry Data for DLL3 Targeting Radiotherapeutic MPO712 Transcript - Seeking Alpha
- 2 months ago - Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026 - GlobeNewsWire
- 2 months ago - Molecular Partners AG (MOLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha